2006 / Narrative review
Grapefruit can alter the metabolism of many oral medications, but non-interacting drug alternatives or dietary substitution can prevent adverse interactions.
This review discusses the management of grapefruit-drug interactions. Grapefruit affects the metabolism of medications that undergo extensive intestinal cytochrome P450 3A4 metabolism, have low bioavailability, or possess a narrow therapeutic index, such as statins, antiarrhythmic agents, immunosuppressants, and calcium channel blockers. Management strategies include substituting equally effective alternative drugs that do not interact with grapefruit or excluding grapefruit from the diet and opting for other fruits, including other types of citrus.
Stump AL, Mayo T, Blum A Am Fam Physician, 2006. PMID 16939181